Fenghuang Zhan

5PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 09, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.

Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur

|Mar 01, 2023
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.

Farah Mazahreh, Liyan Mazahreh, Carolina Schinke

|Nov 02, 2022
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity.

Timon A Bloedjes, Guus de Wilde, Gerarda H Khan

|May 23, 2015
Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics.

Fenghuang Zhan, Maurizio Zangari, Lugui Qiu

|Feb 24, 2015
Role of NEK2A in human cancer and its therapeutic potentials.

Jiliang Xia, Reinaldo Franqui Machin, Zhimin Gu

Pageof 1